Patent US3852435A successfully refreshed from Google Patents.
US3852435A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Uridine-5{40 -diphosphate-glucuronic acid compositions
Assignee: Yamasa Shoyu KK
•
Filing: 1972-10-30
•
Granted: 1974-12-03
•
Expires: 1992-10-30
Abstract
Abstract Pharmaceutical compositions characterized by accelerating action for glucuronide formation comprising uridine-5''-diphosphateglucuronic acid or its pharmaceutically acceptable salt in admixture with pharmaceutical carriers.
Inventors
- 👤 S Tamura
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 17:27
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
44 words
A PHARMACEUTICAL COMPOSITION AS AN ACCELERATOR FOR GLUCURONIDE FORMATION IN A DOSAGE UNIT FORM SELECTED FROM THE GROUP CONSISTING OF POWDER, TABLETS, PILLS CAPSULES, DRAGEES AND AQUEOUS SOLUTIONS COMPRISING URIDINE-5''-DIPHOSPHATE GLUCURONIC ACID OR ITS SODIUM SALT AS AN ACTIVE INGREDIENT AND A PHARMACEUTICAL CARRIER.
Claim 2
Dependent Claim
44 words
A PHARMACEUTICAL COMPOSITION AS AN ACCELERATOR FOR GLUCURONIDE FORMATION IN A DOSAGE UNIT FORM SELECTED FROM THE GROUP CONSISTING OF POWDER, TABLETS, PILLS CAPSULES, DRAGEES AND AQUEOUS SOLUTIONS COMPRISING URIDINE-5''-DIPHOSPHATE GLUCURONIC ACID OR ITS SODIUM SALT AS AN ACTIVE INGREDIENT AND A PHARMACEUTICAL CARRIER.
Claim 3
Dependent Claim
25 words
A pharmaceutical composition according to claim 1, wherein each dosage unit contains from 50 mg to 500 mg of uridine-5''-diphosphate-glucuronic acid as its sodium salt.
Claim 4
Dependent Claim
25 words
A pharmaceutical composition according to claim 1 wherein each dosage unit contains from 20 mg. to 1,000 mg. of uridine-5''-diphosphate-glucuronic acid as its sodium salt.
Claim 5
Dependent Claim
24 words
A pharmaceutical carrier according to claim 1 wherein the carrier is lactose, starch, calcium phosphate, talc, magnesium stearate, polyvinyl pyrrolidone carboxymethyl cellulose or gelatine.
Claim 6
Independent Claim
26 words
A method of treating human beings for ailments requiring treatment to increase the glucuronide forming ability which comprises administering to such patient the composition of claim
Claim 7
Dependent Claim
27 words
A method of treating human beings for ailments requiring treatment to increase the glucuronide forming ability which comprises administering to such patient the composition of claim 2.
Claim 8
Dependent Claim
27 words
A method of treating human beings for ailments requiring treatment to increase the glucuronide forming ability which comprises administering to such patient the composition of claim 3.
Claim 9
Dependent Claim
27 words
A method of treating human beings for ailments requiring treatment to increase the glucuronide forming ability which comprises administering to such patient the composition of claim 4.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1977-12-02 | 1978-06-03 | 1978-12-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1981-12-02 | 1982-06-03 | 1982-12-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1985-12-02 | 1986-06-03 | 1986-12-03 | $7700.00 | Window Closed / Lapsed |